Portfolio company
Indee Labs
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Indee Labs develops microfluidic cell engineering instruments for pharmaceutical and biotechnology companies to deliver gene-editing materials into immune cells for therapeutic development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CellFE
The company develops microfluidic platforms for intracellular delivery of molecules to support cell therapy developers and researchers in manufacturing engineered cells.
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
Inside Therapeutics
The company develops microfluidic instruments for encapsulating therapeutic RNA into lipid nanoparticles for pharmaceutical researchers and nanomedicine manufacturers.
Trince
This company develops laser-based intracellular delivery technology for biopharmaceutical companies and research institutions to facilitate drug discovery and cell therapy development.
Basilard Biotech
Basilard Biotech develops gene delivery technology for cell and gene therapy manufacturers to facilitate nanomechanical engineering of cell-based treatments.
Nanocellect Biomedical
This company develops microfluidic cell sorting instruments and consumables for biomedical researchers in drug discovery, genomics and cell line development.
Mekonos
The company develops a silicon-based system-on-a-chip platform for automated ex vivo delivery of molecular cargo into individual cells for cell and gene therapy developers.
